EZZ Life Science Holdings Limited

EZZ

EZZ Life Science Holdings Ltd. is a genomic life science company, which engages in the business of formulating, producing, marketing, and selling branded health and wellbeing products to retailers and consumers domestically and internationally. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-03-03. The firm has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), children's health, and weight management. The firm's segments include Brought in Lines and Company Owned products. Its portfolio includes EZZ and EAORON. The EZZ-branded product range encompasses a broad selection of health and wellbeing products, catering to individuals across all age groups and owned by the Company. The EAORON-branded products comprise a range of facial care items, and the Company serves as the exclusive distributor in Australia and New Zealand for selected channels. The EZZ-branded products include EZZ Hair Growth Spray Duo, EZZ Multi Vitamins Milk Powder for Children (for children ages three plus), EZZ KidzSure Formulated Nutrition Powder (for children ages three plus) and EZZ VitalSure Formulated Nutrition Powder (for adults).

BetaShares Ftse 100 ETF

F100

F100.AX was created on 2019-07-12 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to track the price and income performance of the FTSE 100 Index (before fees and expenses). The Index provides exposure to the largest 100 comoanies traded on the London Stock Exchange, based on their market capitalisation.